Browsing by Author Gelber, Richard

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2013Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, Aron (Prof); Maibach, Rudolph; Pagani, Olivia; Price, Karen; Rabaglio, Manuela; Regan, Meredith; Ruepp, Barbara; Walley, B; School of Public Health: Public HealthAdjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials, The Breast, vol.22, 6, 2013,pp 1094-1100
2010Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancerCoates, Alan; Cole, Bernard; Crivellari, Diana; Gelber, Richard; Gelber, Shari; Goldhirsch, A; Holmberg, Stig B.; Paridaens, Robert; Price, Karen N.; Thurlimann, B.; School of Public Health: Public HealthAdjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment, vol.123, 1,pp 303-310
2016Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to VCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Forbes, John F.; Gelber, Richard; Gianni, Lorenzo; Goldhirsch, Aron; Karlsson, Per; Price, Karen; Sun, Zhuoxin; Thurlimann, B.; School of Public Health: Public HealthAnnual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V, Journal of Clinical Oncology, vol.34, 9, 2016,pp 927-935
2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-upCoates, Alan; Ejlertsen, Bent; Forbes, John F.; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Neven, Patrick; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, B.; Wardley, Andrew; School of Public Health: Public HealthAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up, Lancet Oncology, vol.12, 12, 2011,pp 1101-1108
2017Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFTCoates, Alan; Abdi, Ehtesham; Colleoni, Marco; Fleming, G. F.; Francis, P A; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Parmar, Vani; Pinotti, Graziella; Regan, Meredith M.; Ruhstaller, Thomas; Salim, Muhammad; Spazzapan, Simon; Tondini, Carlo; Walley, B. A.; NH&MRC Clinical Trials CentreConcurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT, Annals of Oncology, vol.28, 9, 2017,pp 2225-2232
2011Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX.Coates, Alan; Aebi, S; Braun, D; Castiglione-Gertsch, M; Crivellari, Diana; Gelber, Richard; Goldhirsch, A; Gusterson, B. A.; Karlsson, P; Lindtner, Jurii; Price, K. N.; Rabaglio, Manuela; Regan, Meredith M.; Simoncini, Edda; Snyder, Raymond; Sun, Z; Viale, Giuseppe; School of Public Health: Public HealthDifferential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX., Annals of Oncology, vol.22, 9, 2011,pp 1981-1987
2012Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCoates, Alan; O'Toole, Sandra; Castiglione-Gertsch, Monica; Gelber, Richard; Goldhirsch, Aron (Prof); Gusterson, Barry; Millar, E. K. A.; Molloy, T; Musgrove, Elizabeth A.; Regan, Meredith M.; Sun, Zhuoxin; Sutherland, Robert L.; Viale, Giuseppe; School of Public Health: Public Health; Central Clinical School: PathologyPrognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX, Breast Cancer Research, vol.14, 6, 2012,pp 1-12
2015Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialCoates, Alan; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; Filho, Otto Metzger; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Gusterson, B. A.; Mallon, Elizabeth; Price, Karen N; Regan, Meredith; Thurlimann, Beat; Viale, Giuseppe; Winer, Eric P.; School of Public Health: Public HealthRelative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial, Journal of Clinical Oncology, vol.33, 25, 2015,pp 2772-2779